David M. Parham

21.1k total citations · 1 hit paper
330 papers, 13.5k citations indexed

About

David M. Parham is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, David M. Parham has authored 330 papers receiving a total of 13.5k indexed citations (citations by other indexed papers that have themselves been cited), including 199 papers in Pulmonary and Respiratory Medicine, 104 papers in Pathology and Forensic Medicine and 76 papers in Surgery. Recurrent topics in David M. Parham's work include Sarcoma Diagnosis and Treatment (170 papers), Tumors and Oncological Cases (65 papers) and Bone Tumor Diagnosis and Treatments (32 papers). David M. Parham is often cited by papers focused on Sarcoma Diagnosis and Treatment (170 papers), Tumors and Oncological Cases (65 papers) and Bone Tumor Diagnosis and Treatments (32 papers). David M. Parham collaborates with scholars based in United States, United Kingdom and Canada. David M. Parham's co-authors include William H. Meyer, James R. Anderson, Dale A. Ellison, Douglas S. Hawkins, Bruce L. Webber, Frederic G. Barr, Alberto S. Pappo, Harold M. Maurer, Stephen J. Qualman and J. Bruce Beckwith and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

David M. Parham

325 papers receiving 13.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Severe Acquired Immunodeficiency in Male Homosexuals, Manifested by Chronic Perianal Ulcerative Herpes Simplex Lesions

1981 894 citations David M. Parham et al. profile →

Peers

Countries citing papers authored by David M. Parham

Since Specialization

Citations

This map shows the geographic impact of David M. Parham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Parham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Parham more than expected).

Fields of papers citing papers by David M. Parham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Parham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Parham. The network helps show where David M. Parham may publish in the future.

Co-authorship network of co-authors of David M. Parham

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Parham. A scholar is included among the top collaborators of David M. Parham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Parham. David M. Parham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TP53 germline pathogenic variant frequency in anaplastic rhabdomyosarcoma: A Children's Oncology Group report 2023 ·Pediatric Blood & Cancer ·Douglas Fair, Luke Maese, Yueh‐Yun Chi, Minjie Li, Douglas S. Hawkins, Rajkumar Venkatramani, Erin R. Rudzinski, David M. Parham, Lisa A. Teot, David Malkin, Sharon E. Plon, He Li, Aniko Sabo, Philip J. Lupo, Joshua D. Schiffman	4
2	Lymph node metastases in paediatric and young adult patients with non-rhabdomyosarcoma soft tissue sarcoma (NRSTS): Findings from Children's Oncology Group (COG) study ARST0332 2022 ·European Journal of Cancer ·Elysia Alvarez, Jiayi He, Sheri L. Spunt, Andrea Hayes‐Jordan, Simon C. Kao, David M. Parham, Lynn Million, Aaron R. Weiss, Donald A. Barkauskas	7
3	Magnetic resonance and computed tomography imaging features of epithelioid sarcoma in children and young adults with pathological and clinical correlation: a report from Children’s Oncology Group study ARST0332 2019 ·Pediatric Radiology ·M. Beth McCarville, Simon C. Kao, (unknown), Christopher Gaffney, Cheryl M. Coffin, David M. Parham, Andrea Hayes‐Jordan, Sheri L. Spunt	8
4	Clinical features and outcomes of young patients with epithelioid sarcoma: an analysis from the Children's Oncology Group and the European paediatric soft tissue Sarcoma Study Group prospective clinical trials 2019 ·European Journal of Cancer ·Sheri L. Spunt, Nadine Francotte, Gian Luca De Salvo, Yueh-Yun Chi, Ilaria Zanetti, Andrea Hayes‐Jordan, Simon C. Kao, Daniel Orbach, Bernadette Brennan, Aaron R. Weiss, Max M. van Noesel, Lynn Million, Rita Alaggio, David M. Parham, Anna Kelsey, R. Lor Randall, M. Beth McCarville, Gianni Bisogno, Douglas S. Hawkins, Andrea Ferrari	16
5	Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: A report from the Children's Oncology Group 2017 ·Pediatric Blood & Cancer ·Erin R. Rudzinski, James R. Anderson, Yueh‐Yun Chi, Julie M. Gastier‐Foster, Caroline Astbury, Frederic G. Barr, Stephen X. Skapek, Douglas S. Hawkins, Brenda J. Weigel, Alberto S. Pappo, William H. Meyer, Michael Arnold, Lisa A. Teot, David M. Parham	65
6	Shorter-Duration Therapy Using Vincristine, Dactinomycin, and Lower-Dose Cyclophosphamide With or Without Radiotherapy for Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group 2014 ·Journal of Clinical Oncology ·David Walterhouse, Alberto S. Pappo, Jane L. Meza, John C. Breneman, Andrea Hayes‐Jordan, David M. Parham, Timothy P. Cripe, James R. Anderson, William H. Meyer, Douglas S. Hawkins	100
7	A Novel Algorithm for Simplification of Complex Gene Classifiers in Cancer 2013 ·Cancer Research ·(unknown), (unknown), (unknown), (unknown), Aliya N. Husain, David M. Parham, Timothy J. Triche, Michele R. Wing, Julie M. Gastier-Foster, Frederic G. Barr, Douglas S. Hawkins, James R. Anderson, Stephen X. Skapek, Samuel L. Volchenboum	4
8	Dense Pattern of Embryonal Rhabdomyosarcoma, a Lesion Easily Confused With Alveolar Rhabdomyosarcoma 2013 ·American Journal of Clinical Pathology ·Erin R. Rudzinski, Lisa A. Teot, James R. Anderson, Julie Moore, Julia A. Bridge, Frederic G. Barr, Julie M. Gastier‐Foster, Stephen X. Skapek, Douglas S. Hawkins, David M. Parham	66
9	Histologic and Clinical Characteristics Can Guide Staging Evaluations for Children and Adolescents With Rhabdomyosarcoma: A Report From the Children's Oncology Group Soft Tissue Sarcoma Committee 2013 ·Journal of Clinical Oncology ·Aaron R. Weiss, Elizabeth Lyden, James R. Anderson, Douglas S. Hawkins, Sheri L. Spunt, David Walterhouse, Suzanne L. Wolden, David M. Parham, David A. Rodeberg, Simon C. Kao, Richard B. Womer	75
10	Randomized Phase II Window Trial of Two Schedules of Irinotecan With Vincristine in Patients With First Relapse or Progression of Rhabdomyosarcoma: A Report From the Children's Oncology Group 2010 ·Journal of Clinical Oncology ·Leo Mascarenhas, Elizabeth Lyden, Philip P. Breitfeld, David Walterhouse, Sarah S. Donaldson, Charles N. Paidas, David M. Parham, James R. Anderson, William H. Meyer, Douglas S. Hawkins	80
11	Current concepts in pediatric pathology 2010 ·Saunders eBooks ·David M. Parham	1
12	Use of a novel FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of alveolar rhabdomyosarcoma 2006 ·Laboratory Investigation ·Jun Nishio, Pamela A. Althof, Jacqueline Bailey, Ming Zhou, James R. Neff, Frederic G. Barr, David M. Parham, Lisa A. Teot, Stephen J. Qualman, Julia A. Bridge	56
13	Pediatric neoplasia : morphology and biology 1996 ·David M. Parham	62
14	Summary of the International Symposium on Childhood Non-Rhabdomyosarcoma Soft-Tissue Sarcomas, Padua, Italy, February 10–12, 1994 1996 ·Medical and Pediatric Oncology ·Beverly Raney, David M. Parham, (unknown), Michaël C.G. Stevens, J. Treuner, Modesto Carli	5
15	Myofibrosarcoma of the Head and Neck in Children 1995 ·Pediatric Pathology & Laboratory Medicine ·D. M. Smith, Hazem H. Mahmoud, Jesse J. Jenkins, Bhaskar Rao, Kenneth P. Hopkins, David M. Parham	60
16	Asynchronous bilateral retinoblastoma: the St. Jude Children's Research Hospital experience 1995 ·Ophthalmic Genetics ·James Fontanesi, C B Pratt, David Meyer, (unknown), David M. Parham, Sue C. Kaste	8
17	Second malignant neoplasms in children with retinoblastoma: the St. Jude Children's Research Hospital experience 1995 ·Ophthalmic Genetics ·James Fontanesi, David M. Parham, Charles B. Pratt, David Meyer	23
18	Intrathoracic Desmoid Tumor: CT and MRI Appearance 1994 ·Southern Medical Journal ·Helen T. Winer-Muram, Laura C. Bowman, David M. Parham	23
19	Rhabdomyosarcomas and other soft tissue sarcomas in pediatric patients 1993 ·Current Opinion in Oncology ·David M. Parham	7
20	A second nonrandom translocation, der(16)t(1;16)(q21;q13), in Ewing sarcoma and peripheral neuroectodermal tumor 1990 ·Cytogenetic and Genome Research ·E C Douglass, Susan Rowe, M B Valentine, David M. Parham, William H. Meyer, Elizabeth I. Thompson	66

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact